PCD Pharma Franchise for Dry Syrup Suspension

 

Demand for PCD Pharma Franchise for Dry Syrup Suspension company in India- Dokcare Lifesciences

The pharmaceutical industry has a specific place for pcd pharma franchise for dry syrup suspension. Dry syrup formulations not only support medical treatments but also offer fantastic business and career opportunities. If you’re ready to enter the syrup market, join forces with us to obtain a reputable PCD Pharma Franchise for Dry Syrup Suspension.

Dokcare Lifesciences is a well-known producer, supplier, and distributor of PCD Pharma Franchise for Dry Syrup Suspension . The pharmaceutical company, which has received ISO certification, oversees crucial medical prospects and production processes to create healthcare formulations with a quality-first focus. Additionally, it has a group of experienced professionals, including doctors and scientists, who work tirelessly to create effective medications in accordance with consumer demand and market trends.

Due to the advantages of its high quality, dry syrup’s market demand in India is still expanding significantly. People now frequently choose this drug, helping to improve the demand curve through successful outcomes. Similar to how the syrup’s ingredients contain powerful chemicals that can aid patients in overcoming a variety of health issues.

Therefore, according to industry assessments, the need for dry syrups in the nation is projected to increase, opening up a wide range of business chances for entrepreneurs as well. In order to understand the strength and commercial potential of the pharmaceutical sector in India, let’s take a look at some figures from the pcd pharma franchise for dry syrup suspension industry:

• Over 50% of the global demand for various drugs is met by India.
• In terms of output by volume and value, it ranks third and fourteenth globally, respectively.
• The Indian domestic circuit is predicted to increase from US$ 42 billion in 2021 to US$ 65 billion in 2024.
• Cough syrup sales were estimated to be worth $5,232 million globally in 2019.
• It is anticipated to increase by US$ 6,108 million by 2027, with a CAGR of 2.8% from 2020 to 2027.
• The global market for cough syrup has seen a moderate development trend between 2015 and 2020.

Product List of Top PCD Pharma Franchise for Dry Syrup Suspension Company in India

Here is the list of some pharma products of our company along with the compositions: 

Tablet	JEOCIN- 500CIXDOP- O OGLITE- 200  LOKSET DOXODOT- 80  PENTRIC 40  FLUBOW- 400 PIRIL ALZAP- IM	AZITHROMYCIN 500 MGCEFIXIME 200 MG + OFLOXACIN 200 MG OFLOXACIN 200 MG LEVOCETIRIZINE HCL 5 MG DROTAVERINE HYDROCHLORIDE 80 MG PANTOPRAZOLE 40 MG FLUCONAZOLE 400 MG  PIROXICAM 20 MG ALBENDAZOLE 400 MG + IVERMECTIN 6 MG
Capsule	PREBITMECIPRO- L ODRAL ITADERM- 200	PRE & PROBIOTIC CAPSULESESOMEPRAZOLE 40 MG + LEVOSULPIRIDE 75 MG OMEPRAZOLE 20 MG CAPSULE ITRACONAZOLE 200 MG
Suspension	JEOCIN- 200 ALZAP- IM ODIWEL TYRIT FOLCRET	AZITHROMYCIN 200 MGALBENDAZOLE 200 MG + IVERMECTIN 3 MG  ONDANSETRON 2 MG MAGALDRATE 400 MG + SIMETHICONE 20 MG  DEFLAZACORT 6 MG SUSP
INJECTION	DIXAID AQ INJ. PIRIL INJ MECIPRO NJ  ODIWEL INJ	DICLOFENAC SODIUM INJPIROXICAM INJ ESOMEPRAZOLE INJECTION  ONDANSETRON 4 MG / 2 ML
OINTMENT	OFLADERM- OZ	OFLOXACIN 0.75% W/W + ORNIDAZOLE 2% W/W + TERBINAFINE HCL 1% W/W + CLOBETASOL PROPIONATE 5% W/W
DROPS	DOKIMSpasten Drops  DOLYSE- L  C- SQUARE PARAXMOL	CEFPODOXIME 25 MG DROPSDICYCLOMINE 10 MG + DIMETHICONE 40 MG MULTIVITAMIN + MINERALS CHOLECALCIFEROL 800 I.U. PARACETAMOL 100 MG
DRY SYRUP	CIXDOP- O DOKIM-100 CEFUZIL	CEFIXIME 50 MG + OFLOXACIN 50 MGCEFPODOXIME 100 MG CEFUROXIME AXETIL 125 MG WITH WFI
SOFTGEL CAP	QBONE- CZTYBOL- ALA	CALCIUM CARBONATE 500 MG + CALCITRIOL 0.25 MG + ZINC SULPHATE MONOHYDRATE 7.5 MGMETHYLCOBALAMIN 1500 MCG , ALPHA LIPOIC ACID 100 MG+ PYRIDOXINE HCL 3 MG
Others	SCALOT SOAP DIXAID OIL  C- Square Shot PEPORIL Syrup	PERMETHRIN SOAPPAIN RELIEVING OIL CHOLECALCIFEROL 60,000 I.U FUNGAL DIASTASE (1:1200 ) + PEPSIN (1:3000) SYRUP

Contact Information

Contact Dokcare Lifesciences, if you want to get any details regarding Top PCD Pharma Franchise for Dry Syrup Suspension Company in India or any other details regarding our company. 

Company Name: Dokcare Lifesciences

Company Address: Plot no 295, Industrial area phase- 2, Panchkula- 134 109, Haryana (India)

Phone Number: +91- 90236 39358, +91- 90410 39358

Email: dokcarelifesciences@gmail.com 

Website: www.dokcarelifesciences.com